This video, shared by the Pulmonary Fibrosis Foundation, is of a webinar filmed at the PFF Summit: From Bench to Bedside held in Washington D.C. in November 2015.
Dr. Charlene D. Fell presents a talk about pharmacologic therapy and discusses two drugs which were approved for use in the treatment of pulmonary fibrosis in October 2014: pirfenidone and nintedanib. She explains how these medications work in treating the disease and talks about how the FDA came to approve the therapies following the results of clinical trials.
Pulmonary Fibrosis News is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or another qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.
We are sorry that this post was not useful for you!
Let us improve this post!
Tell us how we can improve this post?